title: Patent watch: Indian patent office rejects HIV drug formulation patent.
authors.forename: Charlotte
authors.initials: C
authors.lastname: Harrison
mesh_terms: D019380:Anti-HIV Agents / Q000737:chemistry / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007194:India; D061466:Lopinavir; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011744:Pyrimidinones / Q000737:chemistry / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D011744:Pyrimidinones; D061466:Lopinavir